|
|
|
Volumn 26, Issue 3 SUPPL. 10, 1999, Pages 25-28
|
|
Docetaxel (Taxotere) and neoadjuvant chemotherapy for non-small cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
ADULT;
AGED;
CANCER ADJUVANT THERAPY;
CANCER CONTROL;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL TIME;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0032812703
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (27)
|
